Shopping Cart
- Remove All
- Your shopping cart is currently empty
Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.083 € | 10-14 weeks | |
50 mg | 1.415 € | 10-14 weeks | |
100 mg | 2.242 € | 10-14 weeks |
Description | Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc |
Targets&IC50 | HIV-1 (MOKW):0.2 nM (IC50), HIV-1 (JRFL):0.1 nM (IC50), HIV-1 (Ba-L):0.4 nM (IC50) |
Alias | GW873140A, GW-873140, GW873140, Aplaviroc HCl, AK-602, AK602, AK 602 |
Molecular Weight | 614.17 |
Formula | C33H44ClN3O6 |
Cas No. | 461023-63-2 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.